Intensity Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.

About INTS

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. 

CEO
Lewis H. Bender
CEOLewis H. Bender
Employees
16
Employees16
Headquarters
Shelton, Connecticut
HeadquartersShelton, Connecticut
Founded
2012
Founded2012
Employees
16
Employees16

INTS Key Statistics

Market cap
7.06M
Market cap7.06M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
Dividend yield
Average volume
7.31M
Average volume7.31M
High today
$0.28
High today$0.28
Low today
$0.1853
Low today$0.1853
Open price
$0.271
Open price$0.271
Volume
9.46M
Volume9.46M
52 Week high
$4.93
52 Week high$4.93
52 Week low
$0.1853
52 Week low$0.1853

People also own

Based on the portfolios of people who own INTS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.